A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.

Clinical trial NCT00519376 · COMPLETED

Trial details

NCT number: NCT00519376
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2007-08-01
Primary completion: 2007-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.